1 | line | 6,474 |
2 | intension | 9 |
3 | microanalyzer | 6 |
4 | tsgh | 6 |
5 | v.5.0 | 5 |
6 | hnmamq | 4 |
7 | battifora | 3 |
8 | gapdh-depleted | 3 |
9 | gnrh/hcg | 3 |
10 | line-specific | 3 |
11 | rhogdi2-overexpressing | 3 |
12 | ti-stimulated | 3 |
13 | wall-associated | 3 |
14 | web-space | 3 |
15 | count-guided | 2 |
16 | culture-adapted | 2 |
17 | dilazep-treated | 2 |
18 | endoderm-like | 2 |
19 | fura-2-loaded | 2 |
20 | ifn-γ-primed | 2 |
21 | lps‑stimulated | 2 |
22 | neuronal-like | 2 |
23 | nontumorigenic/immortalized | 2 |
24 | nonvirgins | 2 |
25 | ogd-treated | 2 |
26 | osteocyte-like | 2 |
27 | phone-supported | 2 |
28 | pnttu-treated | 2 |
29 | post-compared | 2 |
30 | rsf1-overexpressing | 2 |
31 | tbx1-knockdown | 2 |
32 | transplantation-specific | 2 |
33 | wall-active | 2 |
34 | 1-phenyl-2,3-dimethyl-4- | 1 |
35 | 15p-1 | 1 |
36 | 5-fu-pretreated | 1 |
37 | 5f203-resistant | 1 |
38 | 6w-treated | 1 |
39 | acmnv-infected | 1 |
40 | ae-resistant | 1 |
41 | af-resistant | 1 |
42 | anti-in | 1 |
43 | aponeurosis- | 1 |
44 | ar-treated | 1 |
45 | araneoid | 1 |
46 | as-af | 1 |
47 | av-ext-treated | 1 |
48 | biochemical-recurrent | 1 |
49 | bnfa-d-treated | 1 |
50 | carcinoma.the | 1 |
51 | cd20-expressing | 1 |
52 | chlorocoercia | 1 |
53 | choice-conditioning | 1 |
54 | contact-mediated | 1 |
55 | cycle-independent | 1 |
56 | cycle-targeting | 1 |
57 | deciduas/decidual | 1 |
58 | degranulation-induced | 1 |
59 | denv-infected | 1 |
60 | double-transfected | 1 |
61 | dp2-stimulated | 1 |
62 | drillers | 1 |
63 | epo1-treated | 1 |
64 | estrogen-dependant | 1 |
65 | ethanol-intoxicated | 1 |
66 | extra-villous | 1 |
67 | fabp3-knockdown | 1 |
68 | fbln-3-expressing | 1 |
69 | flavor-tagged | 1 |
70 | hnis-transfected | 1 |
71 | hospital-brazil | 1 |
72 | hyalinizing | 1 |
73 | ibmx-stimulated | 1 |
74 | il-3-stimulated | 1 |
75 | impres-sions | 1 |
76 | intermediate/progenitor | 1 |
77 | line-a2-overexpressing | 1 |
78 | lps-/inf-γ-stimulated | 1 |
79 | manganese-treated | 1 |
80 | maturation-like | 1 |
81 | memc-treated | 1 |
82 | monocultured | 1 |
83 | msi-1-knockdown | 1 |
84 | n-smase2-overexpressed | 1 |
85 | neutrophil-like | 1 |
86 | nimbolide-treated | 1 |
87 | nod2-regulated | 1 |
88 | nonnicotine-containing | 1 |
89 | oral-targeted | 1 |
90 | organophosphane | 1 |
91 | osteoblast‑like | 1 |
92 | p53-competent | 1 |
93 | p53deleted | 1 |
94 | p63+ck14+ | 1 |
95 | paste-pbc | 1 |
96 | pi/r-containing | 1 |
97 | pm2.5-0.3-exposed | 1 |
98 | pma-differentiaed | 1 |
99 | polarization/magic | 1 |
100 | postautogamous | 1 |
101 | pr-rich | 1 |
102 | prx3-knockdown | 1 |
103 | pxr-over-expression | 1 |
104 | radioactiv | 1 |
105 | receptor-overexpression | 1 |
106 | rw-stimulated | 1 |
107 | salvage-processed | 1 |
108 | schizogenous | 1 |
109 | score/number | 1 |
110 | significance/atypical | 1 |
111 | sub-confluent | 1 |
112 | supraincisional | 1 |
113 | tbbz-treated | 1 |
114 | tnfalpha-treated | 1 |
115 | tolterodine-er-based | 1 |
116 | transfer-based | 1 |
117 | trkc-expressing | 1 |
118 | wall-damaging | 1 |
119 | wall-disturbing | 1 |
120 | wall-targeting | 1 |
121 | well-proliferated | 1 |
122 | well-reasoned | 1 |
123 | wnt5a-transfected | 1 |
124 | β-ar-expressing | 1 |
1 | 1-phenyl-2,3-dimethyl-4- | 1 |
2 | 15p-1 | 1 |
3 | 5-fu-pretreated | 1 |
4 | 5f203-resistant | 1 |
5 | 6w-treated | 1 |
6 | acmnv-infected | 1 |
7 | ae-resistant | 1 |
8 | af-resistant | 1 |
9 | anti-in | 1 |
10 | aponeurosis- | 1 |
11 | ar-treated | 1 |
12 | araneoid | 1 |
13 | as-af | 1 |
14 | av-ext-treated | 1 |
15 | battifora | 3 |
16 | biochemical-recurrent | 1 |
17 | bnfa-d-treated | 1 |
18 | carcinoma.the | 1 |
19 | cd20-expressing | 1 |
20 | chlorocoercia | 1 |
21 | choice-conditioning | 1 |
22 | contact-mediated | 1 |
23 | count-guided | 2 |
24 | culture-adapted | 2 |
25 | cycle-independent | 1 |
26 | cycle-targeting | 1 |
27 | deciduas/decidual | 1 |
28 | degranulation-induced | 1 |
29 | denv-infected | 1 |
30 | dilazep-treated | 2 |
31 | double-transfected | 1 |
32 | dp2-stimulated | 1 |
33 | drillers | 1 |
34 | endoderm-like | 2 |
35 | epo1-treated | 1 |
36 | estrogen-dependant | 1 |
37 | ethanol-intoxicated | 1 |
38 | extra-villous | 1 |
39 | fabp3-knockdown | 1 |
40 | fbln-3-expressing | 1 |
41 | flavor-tagged | 1 |
42 | fura-2-loaded | 2 |
43 | gapdh-depleted | 3 |
44 | gnrh/hcg | 3 |
45 | hnis-transfected | 1 |
46 | hnmamq | 4 |
47 | hospital-brazil | 1 |
48 | hyalinizing | 1 |
49 | ibmx-stimulated | 1 |
50 | ifn-γ-primed | 2 |
51 | il-3-stimulated | 1 |
52 | impres-sions | 1 |
53 | intension | 9 |
54 | intermediate/progenitor | 1 |
55 | line | 6,474 |
56 | line-a2-overexpressing | 1 |
57 | line-specific | 3 |
58 | lps-/inf-γ-stimulated | 1 |
59 | lps‑stimulated | 2 |
60 | manganese-treated | 1 |
61 | maturation-like | 1 |
62 | memc-treated | 1 |
63 | microanalyzer | 6 |
64 | monocultured | 1 |
65 | msi-1-knockdown | 1 |
66 | n-smase2-overexpressed | 1 |
67 | neuronal-like | 2 |
68 | neutrophil-like | 1 |
69 | nimbolide-treated | 1 |
70 | nod2-regulated | 1 |
71 | nonnicotine-containing | 1 |
72 | nontumorigenic/immortalized | 2 |
73 | nonvirgins | 2 |
74 | ogd-treated | 2 |
75 | oral-targeted | 1 |
76 | organophosphane | 1 |
77 | osteoblast‑like | 1 |
78 | osteocyte-like | 2 |
79 | p53-competent | 1 |
80 | p53deleted | 1 |
81 | p63+ck14+ | 1 |
82 | paste-pbc | 1 |
83 | phone-supported | 2 |
84 | pi/r-containing | 1 |
85 | pm2.5-0.3-exposed | 1 |
86 | pma-differentiaed | 1 |
87 | pnttu-treated | 2 |
88 | polarization/magic | 1 |
89 | post-compared | 2 |
90 | postautogamous | 1 |
91 | pr-rich | 1 |
92 | prx3-knockdown | 1 |
93 | pxr-over-expression | 1 |
94 | radioactiv | 1 |
95 | receptor-overexpression | 1 |
96 | rhogdi2-overexpressing | 3 |
97 | rsf1-overexpressing | 2 |
98 | rw-stimulated | 1 |
99 | salvage-processed | 1 |
100 | schizogenous | 1 |
101 | score/number | 1 |
102 | significance/atypical | 1 |
103 | sub-confluent | 1 |
104 | supraincisional | 1 |
105 | tbbz-treated | 1 |
106 | tbx1-knockdown | 2 |
107 | ti-stimulated | 3 |
108 | tnfalpha-treated | 1 |
109 | tolterodine-er-based | 1 |
110 | transfer-based | 1 |
111 | transplantation-specific | 2 |
112 | trkc-expressing | 1 |
113 | tsgh | 6 |
114 | v.5.0 | 5 |
115 | wall-active | 2 |
116 | wall-associated | 3 |
117 | wall-damaging | 1 |
118 | wall-disturbing | 1 |
119 | wall-targeting | 1 |
120 | web-space | 3 |
121 | well-proliferated | 1 |
122 | well-reasoned | 1 |
123 | wnt5a-transfected | 1 |
124 | β-ar-expressing | 1 |
1 | p63+ck14+ | 1 |
2 | 1-phenyl-2,3-dimethyl-4- | 1 |
3 | aponeurosis- | 1 |
4 | v.5.0 | 5 |
5 | 15p-1 | 1 |
6 | chlorocoercia | 1 |
7 | battifora | 3 |
8 | paste-pbc | 1 |
9 | line-specific | 3 |
10 | transplantation-specific | 2 |
11 | polarization/magic | 1 |
12 | pma-differentiaed | 1 |
13 | degranulation-induced | 1 |
14 | fura-2-loaded | 2 |
15 | count-guided | 2 |
16 | flavor-tagged | 1 |
17 | ifn-γ-primed | 2 |
18 | well-reasoned | 1 |
19 | post-compared | 2 |
20 | monocultured | 1 |
21 | tolterodine-er-based | 1 |
22 | transfer-based | 1 |
23 | pm2.5-0.3-exposed | 1 |
24 | salvage-processed | 1 |
25 | n-smase2-overexpressed | 1 |
26 | ethanol-intoxicated | 1 |
27 | epo1-treated | 1 |
28 | tnfalpha-treated | 1 |
29 | memc-treated | 1 |
30 | bnfa-d-treated | 1 |
31 | ogd-treated | 2 |
32 | nimbolide-treated | 1 |
33 | manganese-treated | 1 |
34 | dilazep-treated | 2 |
35 | ar-treated | 1 |
36 | av-ext-treated | 1 |
37 | pnttu-treated | 2 |
38 | 6w-treated | 1 |
39 | tbbz-treated | 1 |
40 | 5-fu-pretreated | 1 |
41 | wall-associated | 3 |
42 | contact-mediated | 1 |
43 | nod2-regulated | 1 |
44 | dp2-stimulated | 1 |
45 | il-3-stimulated | 1 |
46 | ti-stimulated | 3 |
47 | rw-stimulated | 1 |
48 | ibmx-stimulated | 1 |
49 | lps-/inf-γ-stimulated | 1 |
50 | lps‑stimulated | 2 |
51 | well-proliferated | 1 |
52 | denv-infected | 1 |
53 | acmnv-infected | 1 |
54 | wnt5a-transfected | 1 |
55 | double-transfected | 1 |
56 | hnis-transfected | 1 |
57 | oral-targeted | 1 |
58 | p53deleted | 1 |
59 | gapdh-depleted | 3 |
60 | culture-adapted | 2 |
61 | phone-supported | 2 |
62 | nontumorigenic/immortalized | 2 |
63 | araneoid | 1 |
64 | web-space | 3 |
65 | carcinoma.the | 1 |
66 | osteocyte-like | 2 |
67 | neuronal-like | 2 |
68 | neutrophil-like | 1 |
69 | endoderm-like | 2 |
70 | maturation-like | 1 |
71 | osteoblast‑like | 1 |
72 | organophosphane | 1 |
73 | line | 6,474 |
74 | wall-active | 2 |
75 | as-af | 1 |
76 | gnrh/hcg | 3 |
77 | wall-disturbing | 1 |
78 | wall-damaging | 1 |
79 | nonnicotine-containing | 1 |
80 | pi/r-containing | 1 |
81 | choice-conditioning | 1 |
82 | cd20-expressing | 1 |
83 | fbln-3-expressing | 1 |
84 | trkc-expressing | 1 |
85 | β-ar-expressing | 1 |
86 | rsf1-overexpressing | 2 |
87 | line-a2-overexpressing | 1 |
88 | rhogdi2-overexpressing | 3 |
89 | cycle-targeting | 1 |
90 | wall-targeting | 1 |
91 | hyalinizing | 1 |
92 | pr-rich | 1 |
93 | tsgh | 6 |
94 | significance/atypical | 1 |
95 | supraincisional | 1 |
96 | deciduas/decidual | 1 |
97 | hospital-brazil | 1 |
98 | anti-in | 1 |
99 | intension | 9 |
100 | pxr-over-expression | 1 |
101 | receptor-overexpression | 1 |
102 | msi-1-knockdown | 1 |
103 | tbx1-knockdown | 2 |
104 | fabp3-knockdown | 1 |
105 | prx3-knockdown | 1 |
106 | hnmamq | 4 |
107 | score/number | 1 |
108 | microanalyzer | 6 |
109 | intermediate/progenitor | 1 |
110 | nonvirgins | 2 |
111 | impres-sions | 1 |
112 | drillers | 1 |
113 | extra-villous | 1 |
114 | postautogamous | 1 |
115 | schizogenous | 1 |
116 | estrogen-dependant | 1 |
117 | 5f203-resistant | 1 |
118 | ae-resistant | 1 |
119 | af-resistant | 1 |
120 | cycle-independent | 1 |
121 | biochemical-recurrent | 1 |
122 | p53-competent | 1 |
123 | sub-confluent | 1 |
124 | radioactiv | 1 |